retatrutide phase 2 diabetes trial Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Tirzepatide vs. Retatrutide: Key Differences
Description
PMID: 35775116
While GLP-1 drugs alone have low risk, combining them with insulin or sulfonylureas can increase hypoglycemia risk
Henderson Womens Care
Continue to hold the pen in place and count to 5 before removing the needle from the skin
GIP was discovered roughly 50 years later, and GLP-1 in the mid-1980s
3163 which focuses on NAION vision loss allegedly linked to GLP-1s MDL No
